A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

Mise à jour : Il y a 4 ans
Référence : NCT02473393

Femme et Homme

Extrait

To assess safety, efficacy and pharmacokinetics of multiple dosesin patients with Bacterial Enteritis caused by Clostridium difficile infection(CDI) or Enteric infection.


Critère d'inclusion

  • Bacterial Enteritis

Liens